J. Shak, J. Whitaker, B. Ribner
Jan 5, 2011
Citations
0
Influential Citations
25
Citations
Quality indicators
Journal
Journal of Clinical Microbiology
Abstract
ABSTRACT Amikacin is a first-line treatment for Aeromonas infection due to high efficacy. There are few reports of aminoglycoside-resistant Aeromonas spp. We report a soft tissue infection containing multiple pathogens, including a strain of Aeromonas hydrophila resistant to amikacin, tobramycin, and multiple cephalosporins.